Insulin has been found to boost the expression of glutamine synthetase (GS) mediated by sterol regulatory element-binding protein 1 (SREBP1), and increased GS expression further enhances glutamine-dependent anabolic pathways to promote nucleotide and protein synthesis, lipid droplet (LD) formation, and lipogenesis in breast cancer cells [113]. This evidence concerns the gene GLUL and breast cancer.